netFormulary North Central London NHS
Joint Formulary  
 Search
 Formulary Chapter 12: Ear, nose and oropharynx - Full Chapter
12.03.05  Expand sub section  Treatment of dry mouth
12.03.05  Expand sub section  Local Treatment
BioXtra oral gel
(Dry mouth)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
   
Glandosane oral spray
(Dry mouth)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Glandosane may be prescribed by an accredited Speech and Language Therapist.
 
   
12.03.05  Expand sub section  Systemic treatment
Pilocarpine tablets
(Dry mouth)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Approved for dry mouth (xerostomia) caused by Sjogren’s syndrome or head and neck radiotherapy, for those who have not responded adequately to saliva substitutes. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    •  Restricted to Rheumatology
  • RNOH:
    • Non-formulary
  • UCLH:
    • Restricted to EDH
  • WH:
    • Non-formulary
 
   
 ....
 Non Formulary Items
Aquoral oral spray
(Dry mouth)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
AS Saliva Orthana
(Dry mouth)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Biotene Oralbalance
(Dry mouth)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Oralieve oral spray
(Dry mouth)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Saliveze oral spray
(Dry mouth)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Salivix pastilles
(Dry mouth)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
SST tablets
(Dry mouth)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Xerotin
(Dry mouth)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary